CB1 and CB2 cannabinoid receptors — Drug Target
All drugs that target CB1 and CB2 cannabinoid receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (2)
- Nabilone Oral Capsule · Centre for Addiction and Mental Health · Synthetic cannabinoid · Oncology; Pain Management; Psychiatry
Nabilone is a synthetic cannabinoid that mimics THC by binding to cannabinoid receptors in the central nervous system to produce antiemetic and analgesic effects. - Cesamet™ (nabilone) · NEMA Research, Inc. · Synthetic cannabinoid · Oncology, Anesthesia
Nabilone is a synthetic cannabinoid that mimics THC and binds to cannabinoid receptors in the central nervous system to reduce nausea and vomiting.
Phase 3 pipeline (1)
- Nabilone, flexible dosing · University of Calgary · Synthetic cannabinoid · Pain management, Oncology (chemotherapy-induced nausea and vomiting)
Nabilone is a synthetic cannabinoid that mimics THC and activates cannabinoid receptors in the central nervous system to modulate pain, nausea, and other symptoms.